Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. - Wikidata - awgldk - TriplyDB

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment.

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment.

http://www.wikidata.org/entity/Q35693573

about

The antidiabetic gutsy role of metformin uncovered?Gut microbiota and metabolic syndrome Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - convergence toward clinical trials The Role of Gut Microflora and the Cholinergic Anti-inflammatory Neuroendocrine System in Diabetes Mellitus Gut Microbiota and Lifestyle Interventions in NAFLD Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies Bacterial translocation - impact on the adipocyte compartment The gut-adipose-liver axis in the metabolic syndrome Intestinal permeability--a new target for disease prevention and therapy Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus Implication of inflammatory signaling pathways in obesity-induced insulin resistance Obesity: An Immunometabolic Perspective Gut microbiota and immune crosstalk in metabolic disease Gut Microbiota and Host Reaction in Liver Diseases Immunological contributions to adipose tissue homeostasis The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease Therapeutic targeting of NOD1 receptors Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice Can probiotics modulate human disease by impacting intestinal barrier function?Causality of small and large intestinal microbiota in weight regulation and insulin resistance Nutritional approaches for managing obesity-associated metabolic diseases.Adipose tissue macrophage in immune regulation of metabolism.The microbiota and immune response during Clostridium difficile infection.Metagenome and metabolism: the tissue microbiota hypothesis.[Intestinal microbiota and novel therapeutic perspectives for the treatment of metabolic diseases].Human intestinal microbiota composition is associated with local and systemic inflammation in obesity.Microbial translocation and cardiometabolic risk factors in HIV infection.Microbial succession in the gut: directional trends of taxonomic and functional change in a birth cohort of Spanish infants.Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet Some current applications, limitations and future perspectives of lactic acid bacteria as probiotics Gut microbiota, probiotics and diabetes.Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx.Metabolic tinkering by the gut microbiome: Implications for brain development and function Dietary xylo-oligosaccharide stimulates intestinal bifidobacteria and lactobacilli but has limited effect on intestinal integrity in rats.Association of host and microbial species diversity across spatial scales in desert rodent communities.Microbiota and diabetes: an evolving relationship.Anatomical localization of commensal bacteria in immune cell homeostasis and disease Gut Microbiota and Metabolic Disorders Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling.

P2860

Q22242038-79A215A9-066A-433E-98F4-35958518B457 Q24563886-0E30269B-4805-4496-9DE6-C60F42F66CF2 Q24600527-5D971AA6-1C49-486B-B673-E914495454AC Q26745148-3DD59722-812A-4544-B2B2-A965E69D65E4 Q26749783-F2C665D0-9E1C-4A4A-A00F-EC6A26954345 Q26752979-A1F3AD0D-2A28-46CC-80DC-6120A69D1A03 Q26782979-DCF61C5F-B2CC-4200-BD3A-CD97ED7E46B2 Q26852238-4EA083A2-A81F-4A52-B110-F36149C8D7F5 Q26995575-A0D570DA-1652-4287-98FE-83AF3519CF30 Q27015884-58AC475C-9A03-4E41-8911-C99032F90423 Q27025506-B4C3ACDA-E461-41B4-99F2-3DA368EE9163 Q27500365-0A2577D0-FF7D-487D-87F1-E8724D588905 Q28072140-3D76C583-9CE6-44FA-9184-4BE33C6F4B25 Q28078180-D50BC702-746E-4D85-A364-5D86B03CD8EC Q28083295-B6FB04C0-CEF4-4667-B414-23CCB42AAA84 Q28084995-E2A791CA-1428-47C1-AEF3-A0D7AF41BA8B Q28276657-DDBA8D46-07BD-4685-83B7-100AADCB07D4 Q28676201-4D4E1CA2-F751-4EAF-B760-CA7A02419EAA Q28730963-7DD2F7F4-FA31-4008-947F-20B99648E68E Q28817192-8EE061E1-0E89-46B0-8A6A-7C1527D918E2 Q28828501-B3166D8E-84E1-413C-8D5B-42C834CD5A79 Q30234850-725848DF-6A63-4228-830A-E48D675BAA6E Q30241406-0F0FFFAE-3721-4550-9CF6-52F073F06426 Q30276756-9472C7ED-5BE8-4F9A-9B2A-357E6234DF99 Q30353335-3DDF25C8-C21E-4714-80B6-2F3D723D9A7A Q30353345-55BCABC5-7BCB-494B-AD3D-759538DCF148 Q31113843-9B48DF45-5937-41D7-808B-83C51384002F Q33713895-22E538BA-AF45-4C21-884E-0A430A1F8B00 Q33716566-F4BA103F-5908-4004-9BE3-F6DD6847B9F2 Q33721328-EF4F27B0-03A4-42FF-9057-F06D79749EF1 Q33810967-C8B40A3C-F3EE-4FBD-8D77-7CD2686AA426 Q33831849-DE72015D-C5AE-433D-8417-D093D5627C50 Q34057023-1BB20C47-DEF9-4F4B-942C-DDEC514DA726 Q34129385-0D0FA047-3FBA-430F-8BF0-47969E88661B Q34265824-4A824BEC-A34A-462A-9B0B-50180984A350 Q34400485-B619BA1D-5EF3-4379-A236-8CDA3CE0470A Q34420231-BBF921C2-861F-49C0-8E1B-E76C67CE7C64 Q34425509-70E1A801-D862-4A4C-B431-D497799B6C5A Q34482945-585BBFF8-DD12-4305-99D6-DF4B4AE264DF Q34491604-0C4CC128-C9D4-4862-964A-20EC60AA0346

P2860

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment.

http://www.wikidata.org/entity/Q35693573

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Intestinal mucosal adherence a ...... nisms and probiotic treatment.

@ast

Intestinal mucosal adherence a ...... nisms and probiotic treatment.

@en

type

label

Intestinal mucosal adherence a ...... nisms and probiotic treatment.

@ast

Intestinal mucosal adherence a ...... nisms and probiotic treatment.

@en

prefLabel

Intestinal mucosal adherence a ...... nisms and probiotic treatment.

@ast

Intestinal mucosal adherence a ...... nisms and probiotic treatment.

@en

P1433

Q35693573-C2395A1B-C54F-4A4E-82DC-E98A04E75176

P1476

Q35693573-75F8DDD8-25D4-433F-A32E-E3B2E95EBFA9

P2093

Q35693573-09A4B4C5-97B4-4647-B8C3-92126453D45D

Q35693573-0BAA0D80-4070-469B-970C-FD5276E46829

Q35693573-64620F3F-CA5C-47DC-951D-9964E1818787

Q35693573-74507C7C-F04E-43AF-AB1C-BFD73CAC2746

Q35693573-A3D062EC-7B96-4F36-9D16-72466F504732

Q35693573-A5723292-1A02-4DC9-AD83-51796F2BD222

Q35693573-B3CD42E9-ACEA-43E3-97B5-51BC951D3906

Q35693573-C2943F44-40A4-4D09-AC82-D366970CF5FD

Q35693573-CCFA62C3-4CD0-425E-B7E0-C31FBB66A8D9

Q35693573-F30C80B2-E42B-4FB5-B9D3-D9FA375509BA

P2860

Q35693573-041E2684-0EF1-4141-ABE8-8EC6EA350EE9

Q35693573-07F4C877-15D3-4BF9-91C5-2749B6CBC3A7

Q35693573-08C990B3-3C92-495D-B77D-4C16768C1156

Q35693573-1DCA57AE-1A49-4273-9CE3-4F9DF48D6F8E

Q35693573-28C8A3BD-D244-4761-826C-19935ECB960B

Q35693573-2A066D98-282E-42C1-83DB-1FCDD402D524

Q35693573-2A8BE593-30B3-4D46-B377-C94C44082E17

Q35693573-327579C6-B14C-4910-921F-95B6ADCAC529

Q35693573-352348BC-DAA9-4A2E-AFA9-596AD0F1F6C1

Q35693573-3540763C-DF29-49EF-AA42-216F4344DFC7

P304

Q35693573-26563F2B-DAAA-4807-B4F0-2C88E31E15C8

P31

Q35693573-0C4ECB66-99C5-42F8-8F34-210EDA43124F

P356

Q35693573-B5B15180-336C-41A9-82C9-1AA78B99E894

P433

Q35693573-C9B8C0F4-C937-4187-A860-D22E2FC64F60

P478

Q35693573-71F6AC25-17C1-42FD-8DC8-286E6BCF7D35

P50

Q35693573-2126F6C2-EEA7-48D1-A413-BA3CEA8F1992

Q35693573-3EB8372D-411F-45E2-863A-289E500CFD37

Q35693573-78C30A3C-2FEC-4918-8500-9C6D3A935516

Q35693573-812D721A-3831-4886-92E8-E79201380C6F

P577

Q35693573-5B6E78C3-2C16-4AD8-B5AA-07B9635C5BBD

P5875

Q35693573-AA0DBD7C-296B-42AD-B648-34703F3CFF65

P698

Q35693573-2227A602-B9D6-4211-A174-9CBD7678A1EB

P921

Q35693573-11C85548-A95E-4F28-856B-15B56666DA8C

Q35693573-A0B6BA30-09B6-437B-B874-F3A0B9520009

P932

Q35693573-F137A98D-62F9-4EDD-9C69-72573A660236

P356

P1433

EMBO Molecular Medicine

P1476

Intestinal mucosal adherence a ...... anisms and probiotic treatment

@en

P2093

Aurélie Waget

http://www.w3.org/2001/XMLSchema#string

Christelle Vachoux

http://www.w3.org/2001/XMLSchema#string

Jacques Amar

http://www.w3.org/2001/XMLSchema#string

Luis G Bermúdez-Humarán

http://www.w3.org/2001/XMLSchema#string

Mathieu Bergé

http://www.w3.org/2001/XMLSchema#string

Nina Rautonen

http://www.w3.org/2001/XMLSchema#string

Philippe J Sansonetti

http://www.w3.org/2001/XMLSchema#string

Philippe Langella

http://www.w3.org/2001/XMLSchema#string

Rémy Burcelin

http://www.w3.org/2001/XMLSchema#string

Sampo Lahtinen

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and insulin resistance

Obesity alters gut microbial ecology

An obesity-associated gut microbiome with increased capacity for energy harvest

Inflammation and metabolic disorders

Obesity is associated with macrophage accumulation in adipose tissue

Host-bacterial mutualism in the human intestine

The gut microbiota as an environmental factor that regulates fat storage

Sensing of bacteria: NOD a lonely job

Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response

Leptin modulates the expression of secreted and membrane-associated mucins in colonic epithelial cells by targeting PKC, PI3K, and MAPK pathways

P304

559-572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201100159

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Natalia Smirnova

Arthur C Ouwehand

P577

2011-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229970261

http://www.w3.org/2001/XMLSchema#string

P698

21735552

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3265717

http://www.w3.org/2001/XMLSchema#string